Traduction de «facteur de maladie » (Français → Anglais) :

factor XI deficiency | hemophilia C | Rosenthal's syndrome | plasma thromboplastin antecedent deficiency | PTA deficiency

hemophilia B [ Christmas disease | factor 1X deficiency ]

Christmas disease Deficiency:factor IX (with functional defect) | plasma thromboplastin component [PTC] | Haemophilia B

psychological factors affecting other medical conditions [ psychological and behavioural factors associated with disorders or diseases classified elsewhere ]

factor VII deficiency | stable factor deficiency | proconvertin deficiency

Factors in causation of disease

factors in causation of disease

factor VIII:C | factor VIII | antihemophilic factor | antihemophilic factor A

3.2. Chronic diseases: support European cooperation and networking on preventing and improving the response to chronic diseases including cancer and neurodegenerative diseases, operating within a gender-sensitive framework and taking into account the differences between disease processes in women and men, by sharing knowledge, good practice, promoting education, developing guidelines regarding the underlying environmental factors of chronic diseases and developing joint activities on prevention, including with regard to environmental risk factors; . follow-up work already undertaken; set up a European chronic disease information system ...[+++]with comparable data; support chronic disease screening and early diagnosis of chronic diseases, including voluntary accreditation mechanisms; support the development of European guidelines for prevention and early diagnosis where major inequalities exist.

By identifying, disseminating and promoting the up-take of validated best practices for cost-effective prevention measures focused on the key risk factors, namely smoking, harmful use of alcohol, an unhealthy diet, a sedentary lifestyle and obesity, drug use, and environmental factors, as well as communicable diseases, the Programme will contribute to prevent diseases and promote good health, operating within a gender-sensitive framework, also bearing in mind underlying factors of a social nature, as well as the impact on health of certain disabilities.

Specific activities shall include: understanding the determinants of health (including nutrition, physical activity and gender, and environmental, socio-economic, occupational and climate-related factors); improving health promotion and disease prevention; understanding disease and improving diagnosis and prognosis; developing effective prevention and screening programmes and improving the assessment of disease susceptibility; improving the surveillance of infectious diseases and preparedness for combating epidemics and emerging diseases; developing new and better preventive and therapeutic vaccines and drugs; using in-silico medic ...[+++]ine for improving disease management and prediction; developing regenerative medicine and adapted treatments, and treating disease, including palliative medicine; transferring knowledge to clinical practice and scalable innovation actions; improving health information and better collection and use of health cohort and administrative data; standardised data analysis and techniques; active ageing, and independent and assisted living; individual awareness and empowerment for self-management of health; promotion of integrated care, including psychosocial aspects; improving scientific tools and methods to support policy making and regulatory needs; optimising the efficiency and effectiveness of healthcare provision; and reducing health disparities and inequalities by evidence-based decision making and dissemination of best practice and by innovative technologies and approaches.

Specific activities shall include: understanding the determinants of health (including nutrition, physical activity and gender, and environmental, socio-economic, occupational and climate-related factors); improving health promotion and disease prevention; understanding disease and improving diagnosis and prognosis; developing effective prevention and screening programmes and improving the assessment of disease susceptibility; improving the surveillance of infectious diseases and preparedness for combating epidemics and emerging diseases; developing new and better preventive and therapeutic vaccines and drugs; using in-silico medic ...[+++]ine for improving disease management and prediction; developing regenerative medicine and adapted treatments, and treating disease, including palliative medicine; transferring knowledge to clinical practice and scalable innovation actions; improving health information and better collection and use of health cohort and administrative data; standardised data analysis and techniques; active ageing, and independent and assisted living; individual awareness and empowerment for self-management of health; promotion of integrated care, including psychosocial aspects; improving scientific tools and methods to support policy making and regulatory needs; optimising the efficiency and effectiveness of healthcare provision; and reducing health disparities and inequalities by evidence-based decision making and dissemination of best practice and by innovative technologies and approaches.